Apex(SH:603383)2025-04-25 11:35Financial Performance - The company's operating revenue for Q1 2025 was CNY 141,966,885.80, representing a 3.16% increase compared to CNY 137,615,572.95 in the same period last year[4]. - Net profit attributable to shareholders increased by 31.57% to CNY 21,324,582.60 from CNY 16,208,369.57 year-on-year[4]. - The basic earnings per share rose by 32.03% to CNY 0.1047, while diluted earnings per share increased by 31.56% to CNY 0.1038[5]. - The net profit for Q1 2025 was CNY 20,768,879.68, an increase of 46.5% compared to CNY 14,141,430.06 in Q1 2024[15]. - The operating profit for Q1 2025 was CNY 25,116,381.06, up from CNY 17,122,269.94 in Q1 2024, reflecting a growth of 46.7%[15]. - The total comprehensive income for Q1 2025 was CNY 20,768,879.68, compared to CNY 14,141,430.06 in Q1 2024, indicating a growth of 46.5%[15]. Cash Flow - The net cash flow from operating activities improved significantly, with a net outflow of CNY -91,024,881.13, an improvement from CNY -148,489,818.92 in the same period last year[4]. - Cash inflows from operating activities totaled CNY 84,600,662.35 in Q1 2025, compared to CNY 69,791,290.50 in Q1 2024, marking a growth of 21.2%[17]. - The net cash flow from investing activities was -CNY 208,488,224.63 in Q1 2025, compared to -CNY 70,669,418.81 in Q1 2024[18]. - The ending cash and cash equivalents balance for Q1 2025 was CNY 392,204,899.90, down from CNY 719,247,031.02 in Q1 2024[18]. Assets and Liabilities - Total assets decreased by 3.03% to CNY 1,765,843,792.35 from CNY 1,821,027,155.68 at the end of the previous year[5]. - Current assets totaled CNY 1,398,264,391.35, down 10.2% from CNY 1,556,862,306.51[11]. - Non-current assets increased to CNY 367,579,401.00, up 39.3% from CNY 264,164,849.17[11]. - Total liabilities decreased to CNY 260,375,650.39 from CNY 337,259,947.07, a reduction of 22.8%[12]. - Shareholders' equity increased to CNY 1,505,468,141.96 from CNY 1,483,767,208.61, reflecting a growth of 1.5%[12]. Operating Costs and Expenses - Total operating costs decreased to CNY 125,246,871.88 in Q1 2025 from CNY 129,503,191.76 in Q1 2024, reflecting a reduction of 3.5%[14]. - Research and development expenses for Q1 2025 were CNY 37,242,645.94, down 9.0% from CNY 41,043,867.05 in Q1 2024[14]. - The financial expenses for Q1 2025 showed a significant improvement, with a net income of CNY -2,158,220.74 compared to CNY -4,958,824.32 in Q1 2024[14]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 24,490, with the largest shareholder holding 20.97% of the shares[8]. - The company has not engaged in any significant mergers or acquisitions during the reporting period, focusing instead on internal growth strategies[9]. Revenue and Sales - The company reported a significant increase in sales revenue, with cash received from sales reaching CNY 74,090,666.53 in Q1 2025, compared to CNY 56,364,628.60 in Q1 2024, a rise of 31.4%[17]. - The company recognized non-recurring gains of CNY 4,022,861.63, primarily from government subsidies and other income[6].